Correction to: Nature Reviews Gastroenterology & Hepatology https://doi.org/10.1038/s41575-023-00887-9, published online 13 December 2023.
In the version of the article initially published, the Competing interests section was incorrect and has now been updated to read “F.C.S. has served as a paid advisor/consultant to Caibrate, GoodRx, Pfizer, Eli Lilly, Boehringer Ingelheim, Gelesis, Vida Health, Life Force, Ilant Health, Melli Cell, Novo Nordisk, Clearmind Medicine, and Sweetch.” This change has been made to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stanford, F.C. Author Correction: A new era in obesity management. Nat Rev Gastroenterol Hepatol 21, 294 (2024). https://doi.org/10.1038/s41575-024-00908-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-024-00908-1
